GLP1R and stroke disorder: Weight loss remains the primary treatment, though emergingtherapies such as GLP-1 receptor agonists and SGLT2 inhibitors show promise.Finally, stroke-induced pro-inflammatory and autonomic changes contribute to HFrisk, highlighting the importance of stroke prevention in cardiovascular health.